Nagendran Ramalingam, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
alpha-Synuclein | 15 | 2024 | 765 | 3.000 |
Why?
|
Parkinson Disease | 11 | 2024 | 2892 | 1.060 |
Why?
|
beta-Synuclein | 2 | 2021 | 14 | 0.940 |
Why?
|
Dictyostelium | 4 | 2019 | 70 | 0.670 |
Why?
|
Inclusion Bodies | 4 | 2024 | 279 | 0.660 |
Why?
|
Cell Membrane | 3 | 2021 | 3663 | 0.660 |
Why?
|
Stearoyl-CoA Desaturase | 4 | 2022 | 85 | 0.540 |
Why?
|
Microfilament Proteins | 4 | 2016 | 1136 | 0.470 |
Why?
|
Locomotion | 1 | 2015 | 391 | 0.420 |
Why?
|
Phosphorylation | 5 | 2024 | 8331 | 0.350 |
Why?
|
Fetal Proteins | 1 | 2010 | 99 | 0.350 |
Why?
|
Serine | 2 | 2024 | 831 | 0.340 |
Why?
|
Membrane Lipids | 1 | 2010 | 251 | 0.330 |
Why?
|
Carrier Proteins | 5 | 2019 | 4948 | 0.300 |
Why?
|
Neurons | 6 | 2024 | 9504 | 0.280 |
Why?
|
Phospholipids | 1 | 2010 | 783 | 0.270 |
Why?
|
ras GTPase-Activating Proteins | 2 | 2016 | 95 | 0.250 |
Why?
|
Gene Products, tat | 1 | 2004 | 111 | 0.220 |
Why?
|
Actins | 5 | 2019 | 2064 | 0.220 |
Why?
|
gamma-Synuclein | 1 | 2021 | 9 | 0.200 |
Why?
|
Neuroblastoma | 2 | 2020 | 1265 | 0.190 |
Why?
|
Thiadiazoles | 1 | 2020 | 63 | 0.170 |
Why?
|
Rats | 5 | 2023 | 23839 | 0.170 |
Why?
|
Amino Acid Sequence | 7 | 2023 | 13447 | 0.170 |
Why?
|
Chemokines | 1 | 2004 | 963 | 0.170 |
Why?
|
Microtubules | 3 | 2016 | 1075 | 0.160 |
Why?
|
Lysine | 1 | 2023 | 990 | 0.160 |
Why?
|
NIH 3T3 Cells | 4 | 2016 | 669 | 0.160 |
Why?
|
Pyridazines | 1 | 2020 | 204 | 0.150 |
Why?
|
Guanabenz | 1 | 2018 | 6 | 0.150 |
Why?
|
Synaptic Transmission | 1 | 2024 | 1173 | 0.150 |
Why?
|
Contractile Proteins | 1 | 2019 | 240 | 0.150 |
Why?
|
Lentivirus | 1 | 2021 | 519 | 0.150 |
Why?
|
Antiparkinson Agents | 1 | 2018 | 184 | 0.150 |
Why?
|
Activating Transcription Factor 4 | 1 | 2018 | 86 | 0.140 |
Why?
|
Animals | 18 | 2024 | 169424 | 0.140 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2018 | 93 | 0.140 |
Why?
|
Protein Binding | 3 | 2021 | 9376 | 0.130 |
Why?
|
Mesencephalon | 1 | 2018 | 339 | 0.130 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5808 | 0.130 |
Why?
|
Myosin Type II | 1 | 2015 | 70 | 0.130 |
Why?
|
Melanoma, Experimental | 1 | 2019 | 561 | 0.130 |
Why?
|
Protozoan Proteins | 2 | 2015 | 851 | 0.130 |
Why?
|
Actomyosin | 1 | 2015 | 115 | 0.120 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2024 | 1890 | 0.120 |
Why?
|
Microtubule-Associated Proteins | 3 | 2016 | 1078 | 0.120 |
Why?
|
Phosphatidylinositols | 1 | 2015 | 280 | 0.120 |
Why?
|
Temperature | 1 | 2021 | 2237 | 0.110 |
Why?
|
Small Molecule Libraries | 1 | 2019 | 746 | 0.110 |
Why?
|
Fatty Acids | 1 | 2022 | 1818 | 0.110 |
Why?
|
Conserved Sequence | 3 | 2021 | 1163 | 0.110 |
Why?
|
Actin Capping Proteins | 1 | 2012 | 3 | 0.110 |
Why?
|
Protein Conformation | 2 | 2019 | 3972 | 0.100 |
Why?
|
Hippocampus | 1 | 2023 | 3783 | 0.090 |
Why?
|
Drug Discovery | 1 | 2018 | 1062 | 0.090 |
Why?
|
Protein Structure, Tertiary | 2 | 2010 | 3790 | 0.090 |
Why?
|
Solubility | 2 | 2023 | 1085 | 0.090 |
Why?
|
Models, Molecular | 2 | 2019 | 5441 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1898 | 0.090 |
Why?
|
Amyloid beta-Peptides | 1 | 2023 | 3892 | 0.090 |
Why?
|
Polymerization | 1 | 2010 | 158 | 0.090 |
Why?
|
Cytosol | 2 | 2023 | 889 | 0.080 |
Why?
|
Metabolomics | 1 | 2018 | 1675 | 0.080 |
Why?
|
Rabbits | 1 | 2015 | 4786 | 0.080 |
Why?
|
Mutation | 5 | 2023 | 30235 | 0.080 |
Why?
|
Lipids | 1 | 2019 | 3346 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1905 | 0.080 |
Why?
|
Enzyme Inhibitors | 1 | 2018 | 3734 | 0.070 |
Why?
|
Protein Interaction Domains and Motifs | 2 | 2021 | 452 | 0.070 |
Why?
|
Lewy Body Disease | 2 | 2020 | 253 | 0.070 |
Why?
|
HIV-1 | 1 | 2004 | 6909 | 0.070 |
Why?
|
rhoA GTP-Binding Protein | 2 | 2019 | 237 | 0.070 |
Why?
|
Cell Movement | 2 | 2019 | 5223 | 0.070 |
Why?
|
Protein Multimerization | 2 | 2021 | 979 | 0.060 |
Why?
|
Enzyme Activation | 1 | 2010 | 3594 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2020 | 10490 | 0.060 |
Why?
|
Mice | 9 | 2023 | 82051 | 0.060 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 119 | 0.060 |
Why?
|
Cell Death | 2 | 2020 | 1684 | 0.060 |
Why?
|
Phylogeny | 3 | 2008 | 2841 | 0.050 |
Why?
|
AIDS Dementia Complex | 1 | 2004 | 154 | 0.050 |
Why?
|
Cell Line | 3 | 2019 | 15610 | 0.050 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2023 | 397 | 0.050 |
Why?
|
Binding Sites | 1 | 2010 | 6029 | 0.050 |
Why?
|
rho GTP-Binding Proteins | 2 | 2014 | 279 | 0.050 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2004 | 435 | 0.050 |
Why?
|
Chemotaxis | 1 | 2004 | 601 | 0.050 |
Why?
|
Up-Regulation | 2 | 2020 | 4132 | 0.040 |
Why?
|
Lipoylation | 1 | 2020 | 87 | 0.040 |
Why?
|
Humans | 14 | 2024 | 768369 | 0.040 |
Why?
|
Oleic Acid | 1 | 2018 | 92 | 0.040 |
Why?
|
Diglycerides | 1 | 2018 | 176 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2010 | 5151 | 0.040 |
Why?
|
Oxidopamine | 1 | 2018 | 173 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2004 | 1751 | 0.040 |
Why?
|
Adrenergic Agents | 1 | 2018 | 73 | 0.040 |
Why?
|
PC12 Cells | 1 | 2018 | 317 | 0.040 |
Why?
|
Mutagenesis | 1 | 2021 | 1231 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2020 | 839 | 0.040 |
Why?
|
Protein Phosphatase 1 | 1 | 2018 | 135 | 0.040 |
Why?
|
Lewy Bodies | 1 | 2017 | 141 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2019 | 9558 | 0.030 |
Why?
|
Cell Polarity | 1 | 2019 | 639 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 2019 | 2565 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2018 | 22365 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18390 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2004 | 2590 | 0.030 |
Why?
|
Monocytes | 1 | 2004 | 2589 | 0.030 |
Why?
|
Fibroblasts | 2 | 2016 | 4180 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2017 | 1223 | 0.030 |
Why?
|
Nerve Degeneration | 1 | 2018 | 750 | 0.030 |
Why?
|
Muscle Contraction | 1 | 2019 | 1208 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 939 | 0.030 |
Why?
|
Lysophospholipids | 1 | 2016 | 338 | 0.030 |
Why?
|
Thiazolidines | 1 | 2012 | 70 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2019 | 19035 | 0.030 |
Why?
|
Protein Stability | 1 | 2014 | 584 | 0.020 |
Why?
|
Depsipeptides | 1 | 2012 | 96 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2018 | 892 | 0.020 |
Why?
|
Triglycerides | 1 | 2018 | 2465 | 0.020 |
Why?
|
Signal Transduction | 3 | 2023 | 23639 | 0.020 |
Why?
|
Homeostasis | 1 | 2022 | 3351 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2017 | 2640 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2023 | 3832 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2012 | 856 | 0.020 |
Why?
|
Caenorhabditis elegans | 1 | 2018 | 1462 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2023 | 14483 | 0.020 |
Why?
|
Tyrosine | 1 | 2012 | 1428 | 0.020 |
Why?
|
DNA Damage | 1 | 2018 | 2461 | 0.020 |
Why?
|
Integrins | 1 | 2012 | 845 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2018 | 2680 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8201 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2834 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2020 | 3861 | 0.020 |
Why?
|
Maltose-Binding Proteins | 1 | 2006 | 62 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2012 | 1192 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2018 | 11928 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2008 | 17637 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 17149 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2008 | 1706 | 0.010 |
Why?
|
Models, Biological | 1 | 2019 | 9505 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2018 | 5827 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2006 | 2184 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9526 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2006 | 3735 | 0.010 |
Why?
|
Brain | 1 | 2024 | 27439 | 0.010 |
Why?
|
Female | 1 | 2015 | 396926 | 0.010 |
Why?
|